Analysis of the survival curve indicated that the shT2-CAR-T group experienced a highly significant survival benefit compared to its wild-type counterpart and the control groups (Fig. 6 D).
← all excerpts
TIPE2 knockdown enhances the anti-tumor efficacy of NKG2D CAR-T cells against pancreatic cancer via activating NF-κb signaling pathway.
1
—
—